Table 3.
T-test analysis on the total lifetime costs before and after adding the unrelated future medical costs (£GBP 2017–2018)
Diabetes type | Variable | Observation | Mean | SE | SD | 95% CI | P value (difference <0) | P value (difference != 0) | P value (difference >0) | |
---|---|---|---|---|---|---|---|---|---|---|
T1D | Before | 16 | 54,156 | 8560 | 34,241 | 35,911 | 72,402 | |||
After | 16 | 68,436 | 8408 | 33,633 | 50,514 | 86,358 | ||||
Difference | − 14,280 | 11,999 | − 38,785 | 10,226 | 0.12 | 0.24 | 0.88 | |||
T2D | Before | 28 | 71,511 | 13,277 | 70,255 | 44,269 | 98,753 | |||
After | 28 | 105,422 | 13,971 | 73,930 | 76,755 | 134,089 | ||||
Difference | − 33,911 | 19,274 | − 72,553 | 4730 | 0.04 | 0.08 | 0.96 |
Difference = Before–After
Bolded p-value indicates statistical significance at 0.05 threshold
95% CI 95% confidence interval, SD standard deviation, SE standard error, T1D type 1 diabetes, T2D type 2 diabetes